SCHEMBL18553249

SCHEMBL18553249

Clc1nc(-c2ccc3c(c2)sc2ccccc23)nc2sc3ccc4ccccc4c3c12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.35
▸ HPGD P15428 4/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ MAPT P10636 3/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ NPC1 O15118 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ GPR3 P46089 1/20 0.33
▸ CYP1A1 P04798 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP1B1 Q16678 1/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ NQO1 P15559 1/20 0.32
▸ NQO2 P16083 1/20 0.32
▸ PTGES O14684 1/20 0.31
▸ ELANE P08246 1/20 0.31
▸ LMNA P02545 2/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ APEX1 P27695 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18553231 0.84 NPC1 (0.42) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A
SCHEMBL18666497 0.84 NPC1 (0.43) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A
SCHEMBL21116862 0.82 MAPT (0.41) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A
SCHEMBL19660799 0.80 ALDH1A1 (0.38) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A
SCHEMBL24307102 0.76 ALDH1A1 (0.45) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A
SCHEMBL19786658 0.75 ALDH1A1 (0.38) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A
SCHEMBL22161422 0.75 MAPT (0.40) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A
SCHEMBL15315643 0.75 GPR3 (0.54) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A
SCHEMBL30422699 0.75 GPR3 (0.54) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A
SCHEMBL21707173 0.74 SMN1; SMN2 (0.46) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11299459-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2022-04-12 — — US disclosed
WO-2017030307-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS COMPRISING SAME 덕산네오룩스 주식회사 2017-02-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11299459-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof PIEZO1, OCIAD1, TMEM109 ALDH1A1 540/4885HPGD 3589/4885SMN1; SMN2 1388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback